Examkin

Soru

Zorluk: OrtaEnd-of-Life and Palliative Care

An 81-year-old woman is evaluated in the inpatient palliative care unit. She was admitted four days ago for management of intractable bone pain secondary to metastatic breast cancer. Over the past 24 hours, her level of consciousness has progressively declined, and she is now unresponsive to verbal and tactile stimuli. Her temperature is 37.1°C (98.8°F), blood pressure is 82/40 mm Hg, heart rate is 112/min, and respiratory rate is 14/min with brief periods of apnea. The patient's breathing has become increasingly noisy, characterized by a loud, gurgling sound during both inspiration and expiration. Her daughter, who is the designated healthcare surrogate, is at the bedside and is visibly distressed. She tells the physician, "It sounds like she is choking to death. Please do something to help her." Auscultation of the neck reveals prominent transmitted upper airway noises, while the lung bases are clear to auscultation. The patient is currently receiving a continuous intravenous morphine infusion. Which of the following is the most appropriate next step in management?

  1. Administer sublingual glycopyrrolateCevap
  2. B
    Perform deep nasotracheal suctioning
  3. C
    Administer intravenous furosemide
  4. D
    Transfer the patient to the intensive care unit for airway management
  5. E
    Administer intravenous naloxone

Cevap

The most appropriate next step is to administer an anticholinergic medication such as sublingual glycopyrrolate.
This patient is exhibiting terminal respiratory secretions, commonly referred to as the 'death rattle'. This phenomenon occurs in the final hours to days of life when profound neurological depression leads to a loss of the swallowing and cough reflexes, causing normal salivary and bronchial secretions to pool in the oropharynx. While the sound is often highly distressing to family members, there is no evidence that it causes discomfort to the unresponsive patient. The most appropriate management involves a combination of non-pharmacological measures (such as gentle repositioning or elevating the head of the bed) and pharmacological interventions to reduce secretion production. Anticholinergic agents, such as sublingual glycopyrrolate, sublingual atropine, or transdermal scopolamine, are the treatments of choice. Glycopyrrolate is often preferred because it is a quaternary amine that does not cross the blood-brain barrier, thereby avoiding central anticholinergic side effects like paradoxical agitation.

Adım Adım Çözüm

1
Identify the patient's clinical sign.
Loud, gurgling respirations in an unresponsive, actively dying patient indicate the presence of terminal respiratory secretions, colloquially known as the 'death rattle'.
Accurate identification prevents the misdiagnosis of conditions like pulmonary edema or respiratory failure requiring invasive intervention.
2
Determine the underlying pathophysiology of the symptom.
The symptom is caused by the pooling of salivary and oropharyngeal secretions due to a loss of the swallowing reflex as the patient approaches death.
Understanding that this is a natural dying process guides the clinician toward symptomatic, non-invasive management rather than curative or invasive measures.
3
Select the most appropriate pharmacological and non-pharmacological interventions.
Anticholinergic medications (e.g., glycopyrrolate, atropine drops, scopolamine) are selected to decrease secretion production, combined with gentle repositioning and thorough family education.
These steps maximize patient comfort and address surrogate distress without causing iatrogenic harm.

Anahtar Kavram

Terminal respiratory secretions ('death rattle') in actively dying patients should be managed with family reassurance, patient repositioning, and anticholinergic medications (e.g., glycopyrrolate, scopolamine) rather than invasive suctioning.
Tahmini Süre:1m 15s
Bu soruyu puanla

Konular

End-of-Life and Palliative Care

Bu konudan daha fazla soru